In this present study, we identified an inhibitory role for TRIP12 in suppressing epithelial-mesenchymal transition (EMT) and mesenchymal traits through regulating ZEB1/2 gene expression, contrary to its tumor-promoting role in cancer initiation. Here, TRIP12 is linked to cancer.